{"id":26639,"date":"2023-03-29T09:26:25","date_gmt":"2023-03-29T09:26:25","guid":{"rendered":"https:\/\/www.hri-research.org\/?p=26639"},"modified":"2023-03-29T10:15:17","modified_gmt":"2023-03-29T10:15:17","slug":"study-highlights-no-4-2023-breast-cancer-patients-benefit-from-add-on-homeopathic-treatment-a-large-cohort-study-in-france","status":"publish","type":"post","link":"https:\/\/www.hri-research.org\/sv\/2023\/03\/study-highlights-no-4-2023-breast-cancer-patients-benefit-from-add-on-homeopathic-treatment-a-large-cohort-study-in-france\/","title":{"rendered":"Study Highlights No. 4\/2023 &#8211; Breast cancer patients benefit from add-on homeopathic treatment: a large cohort study in France"},"content":{"rendered":"<p>Quality of life benefits of homeopathy \u2013 several studies have investigated this topic in recent years. In this fourth issue of our \u201cStudy Highlights series\u201d, we present a recently published retrospective cohort study based on the French nationwide healthcare database. The study, which analysed 98,009 women who underwent mastectomy for newly diagnosed non-metastatic breast cancer, showed the benefits of add-on homeopathic treatment in helping women better tolerate cancer treatment side effects.<\/p>\n<p><a href=\"https:\/\/www.hri-research.org\/wp-content\/uploads\/2023\/03\/HRI-press-release-Medioni_ENG_final.pdf\">Press Release (PDF)<\/a><\/p>\n<p><strong>Contact<\/strong>:<br \/>\nHomeopathy Research Institute, Berlin, Germany<br \/>\nChristoph Trapp<br \/>\nPhone: +49 (0)170 9917 649<br \/>\nE-Mail <a href=\"mailto:presse@hri-research.org\">presse@hri-research.org<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Quality of life benefits of homeopathy \u2013 several studies have investigated this topic in recent years. In this fourth issue of our \u201cStudy Highlights series\u201d, we present a recently published retrospective cohort study based on the French nationwide healthcare database. The study, which analysed 98,009 women who underwent mastectomy for newly diagnosed non-metastatic breast cancer, [&hellip;]<\/p>\n","protected":false},"author":835,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[18],"tags":[],"class_list":["post-26639","post","type-post","status-publish","format-standard","hentry","category-press-releases"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.hri-research.org\/sv\/wp-json\/wp\/v2\/posts\/26639","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hri-research.org\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hri-research.org\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hri-research.org\/sv\/wp-json\/wp\/v2\/users\/835"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hri-research.org\/sv\/wp-json\/wp\/v2\/comments?post=26639"}],"version-history":[{"count":0,"href":"https:\/\/www.hri-research.org\/sv\/wp-json\/wp\/v2\/posts\/26639\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.hri-research.org\/sv\/wp-json\/wp\/v2\/media?parent=26639"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hri-research.org\/sv\/wp-json\/wp\/v2\/categories?post=26639"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hri-research.org\/sv\/wp-json\/wp\/v2\/tags?post=26639"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}